Thymidine labeling index and Ki-67 growth fraction in breast cancer: Comparison and correlation with prognosis
- 1 January 1994
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 32 (2) , 165-175
- https://doi.org/10.1007/bf00665767
Abstract
In situ determination of proliferative activity was performed on 184 consecutive primary invasive breast cancers. Methods used were monoclonal antibody Ki-67 in immunohistochemistry and thymidine labeling index. Tumor proliferation correlated between both methods (p = 0.0001). For thymidine labeling index and Ki-67, respectively, significant correlations existed with histologic tumour grade and steroid hormone receptors (Tumor grade: TLIp = 0.0001; Ki-67 p = 0.0001. ER-ICA: TLI = 0.0001; Ki-67 p = 0.014. PgR-ICA: TLIp = 0.0001; Ki-67 p = 0.0008). For thymidine labeling index a significant correlation was demonstrated for overall survival (p = 0.001) and recurrence free survival (p = 0.01). No statistical significance was observed for clinical outcome and Ki-67 (overall survival p = 0.18; recurrence free survival p = 0.1). None of the factors, TLI or Ki-67, was an independent prognostic factor as demonstrated by multivariate analysis.Keywords
This publication has 41 references indexed in Scilit:
- Breast cancer and timing of surgery during menstrual cycle. A 5‐year analysis of 385 pre‐menopausal womenInternational Journal of Cancer, 1992
- DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised studyEuropean Journal Of Cancer, 1992
- Feasibility and reproducibility of the [3H]‐thymidine labelling index in breast cancerCell Proliferation, 1991
- Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67Breast Cancer Research and Treatment, 1991
- K-67 Immunoreactivity in Breast Carcinomas in Relation to Transferrin Receptor Expression, Estrogen Receptor Status and Morphological CriteriaOncology, 1989
- Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptorsBreast Cancer Research and Treatment, 1988
- Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancerBreast Cancer Research and Treatment, 1986
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- In VitroLabeling of Solid Tissues with Tritiated Thymidine for Autoradiographic Detection of S-Phase NucleiStain Technology, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958